Clinical Trial Update: Upadacitinib in Patients Hospitalized With Acute Severe Ulcerative Colitis [Phase 4]

View source ↗

Summary

This is a Phase 4 trial evaluating Upadacitinib in hospitalized patients with acute severe ulcerative colitis; the study is currently not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• RINVOQ (Upadacitinib)

Snippet

Sponsor: University of California, San Francisco | Conditions: UC - Ulcerative Colitis | Phase 4 | Status: NOT_YET_RECRUITING